I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Combination of Nanovectorized siRNA Directed against Surviv..:
Sahar Eljack
;
Emilie Allard-Vannier
;
Yoann Misericordia
...
https://www.mdpi.com/1999-4923/14/11/2537. , 2022
Link:
https://doi.org/10.3390/pharmaceutics14112537
RT Journal T1
Combination of Nanovectorized siRNA Directed against Survivin with Doxorubicin for Efficient Anti-Cancer Activity in HER2+ Breast Cancer Cells
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:0afbba0fe3664611aecaf245fbd86a57&Exemplar=1&LAN=DE A1 Sahar Eljack A1 Emilie Allard-Vannier A1 Yoann Misericordia A1 Katel Hervé-Aubert A1 Nicolas Aubrey A1 Igor Chourpa A1 Areeg Faggad A1 Stephanie David PB MDPI AG YR 2022 K1 siRNA K1 targeted nanovector K1 HER2+ K1 Doxorubicin K1 Survivin K1 Pharmacy and materia medica K1 RS1-441 JF https://www.mdpi.com/1999-4923/14/11/2537 LK http://dx.doi.org/https://doi.org/10.3390/pharmaceutics14112537 DO https://doi.org/10.3390/pharmaceutics14112537 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)